Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 83.11M | $ 16.35M | $ 0 | $ 0 | -19.67% |
3/31/2025 | $ 97.72M | $ 17.54M | $ 0 | $ 0 | -17.95% |
12/31/2024 | $ 79.49M | $ 4.05M | $ 0 | $ 0 | -5.1% |
9/30/2024 | $ 63.35M | $ 7.87M | $ 0 | $ 0 | -12.42% |
6/30/2024 | $ 58.12M | $ 7.86M | $ 0 | $ 0 | -13.52% |
3/31/2024 | $ 88.03M | $ 6.64M | $ 0 | $ 0 | -7.54% |
12/31/2023 | $ 49.32M | $ 6.62M | $ 0 | $ 0 | -13.41% |
9/30/2023 | $ 20.75M | $ 0 | $ 0 | $ 0 | 0% |
6/30/2023 | $ 21.32M | $ 0 | $ 0 | $ 0 | 0% |
3/31/2023 | $ 23.63M | $ 13K | $ 0 | $ 0 | -0.06% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for ENTERA BIO LTD is calculated as follows: (-1 * CF - Equity [ $ 13.61M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -145K ]) / Market Cap [ $ 19.65M ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |